Managing IP Products

Browse Magazine

IP Resources

07 January 2010

Lundbeck faces antitrust investigation

James Nurton, London

The European Commission has opened an antitrust investigation into drugs company Lundbeck, based on information acquired during its sector enquiry into the pharmaceutical industry

The enquiry, completed last year, investigated alleged abuse of competition law by pharmaceutical companies, leading to delays in market entry of generic medicines.

The rest of this article is available to subscribers to Managing IP only.

Subscribe today to this product for full access to this article. Alternatively, take a 48-hour free trial giving you access to the current content.

If you are already a subscriber please log in (see top right column) to access the rest of this article.

IBM faces EU antitrust probe 27 Jul 2010
From RIM to Apple: a roundup of smartphones at war 26 Jul 2010
Harmonisation priorities spelt out for TMs in Europe 19 Jul 2010
Commission notes fall in problematic pharma deals 12 Jul 2010
AstraZeneca ruling could mean more competition cases 01 Jul 2010

Events

Forthcoming conference
Asia-Pacific IP Forum
Sheraton Hotel, Hong Kong
September 1 & 2 2010

Recent web seminar
Listen to archived version
Develop effective patent strategies in Europe

July / August 2010

Meet the 50 most influential people in IP

Managing IP publishes its eighth annual list of the 50 most influential people in IP

Should the .xxx domain be approved?
Yes
No

Disclaimer

Managing Intellectual Property

Navigation Menu

Managing IP Home Page